Discovers and develops engineered biologics and therapeutic enzymes to treat late-life neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Leverages extensive enzyme-engineering experience from metabolic rare-disease programs to design targeted biologic therapies.